U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ALSEVALIMAB
INN  
Official Name English
alsevalimab [INN]
Preferred Name English
IMMUNOGLOBULIN G1 (DE-450-LYSINE), ANTI-(HUMAN B7 HOMOLOG 4 PROTEIN) (HUMAN MONOCLONAL FPA150 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL FPA150 .KAPPA.CHAIN, DIMER
Systematic Name English
FPA-150
Code English
FPA150
Code English
Code System Code Type Description
SMS_ID
300000023652
Created by admin on Wed Apr 02 02:10:28 GMT 2025 , Edited by admin on Wed Apr 02 02:10:28 GMT 2025
PRIMARY
INN
11301
Created by admin on Wed Apr 02 02:10:28 GMT 2025 , Edited by admin on Wed Apr 02 02:10:28 GMT 2025
PRIMARY
NCI_THESAURUS
C155967
Created by admin on Wed Apr 02 02:10:28 GMT 2025 , Edited by admin on Wed Apr 02 02:10:28 GMT 2025
PRIMARY
FDA UNII
U8LYN0Y118
Created by admin on Wed Apr 02 02:10:28 GMT 2025 , Edited by admin on Wed Apr 02 02:10:28 GMT 2025
PRIMARY
CAS
2254029-91-7
Created by admin on Wed Apr 02 02:10:28 GMT 2025 , Edited by admin on Wed Apr 02 02:10:28 GMT 2025
PRIMARY
ACTIVE MOIETY
ALSEVALIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966